These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 24332927)

  • 1. The role of transforming growth factor (TGF)-β in modulating the immune response and fibrogenesis in the gut.
    Biancheri P; Giuffrida P; Docena GH; MacDonald TT; Corazza GR; Di Sabatino A
    Cytokine Growth Factor Rev; 2014 Feb; 25(1):45-55. PubMed ID: 24332927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TGF-β in inflammatory bowel disease: a key regulator of immune cells, epithelium, and the intestinal microbiota.
    Ihara S; Hirata Y; Koike K
    J Gastroenterol; 2017 Jul; 52(7):777-787. PubMed ID: 28534191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor-beta: recent advances on its role in immune tolerance.
    Mantel PY; Schmidt-Weber CB
    Methods Mol Biol; 2011; 677():303-38. PubMed ID: 20941619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming growth factor beta signalling and matrix metalloproteinases in the mucosa overlying Crohn's disease strictures.
    Di Sabatino A; Jackson CL; Pickard KM; Buckley M; Rovedatti L; Leakey NA; Picariello L; Cazzola P; Monteleone G; Tonelli F; Corazza GR; MacDonald TT; Pender SL
    Gut; 2009 Jun; 58(6):777-89. PubMed ID: 19201776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory T cells, transforming growth factor-beta, and immune suppression.
    Wan YY; Flavell RA
    Proc Am Thorac Soc; 2007 Jul; 4(3):271-6. PubMed ID: 17607012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory lymphocytes and intestinal inflammation.
    Izcue A; Coombes JL; Powrie F
    Annu Rev Immunol; 2009; 27():313-38. PubMed ID: 19302043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory cell populations in the intestinal mucosa.
    Goodman WA; Pizarro TT
    Curr Opin Gastroenterol; 2013 Nov; 29(6):614-20. PubMed ID: 24100716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Orally administered TGF-beta is biologically active in the intestinal mucosa and enhances oral tolerance.
    Ando T; Hatsushika K; Wako M; Ohba T; Koyama K; Ohnuma Y; Katoh R; Ogawa H; Okumura K; Luo J; Wyss-Coray T; Nakao A
    J Allergy Clin Immunol; 2007 Oct; 120(4):916-23. PubMed ID: 17606291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smad7 in TGF-beta-mediated negative regulation of gut inflammation.
    Monteleone G; Pallone F; MacDonald TT
    Trends Immunol; 2004 Oct; 25(10):513-7. PubMed ID: 15364052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation and role of transforming growth factor-beta in immune tolerance induction and inflammation.
    Schmidt-Weber CB; Blaser K
    Curr Opin Immunol; 2004 Dec; 16(6):709-16. PubMed ID: 15511662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGF-β in Inflammatory Bowel Diseases: A Tale of the Janus-Like Cytokine.
    Shen Y; Zhang C; Chen Y
    Crit Rev Eukaryot Gene Expr; 2015; 25(4):335-47. PubMed ID: 26559094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired estrogen signaling underlies regulatory T cell loss-of-function in the chronically inflamed intestine.
    Goodman WA; Bedoyan SM; Havran HL; Richardson B; Cameron MJ; Pizarro TT
    Proc Natl Acad Sci U S A; 2020 Jul; 117(29):17166-17176. PubMed ID: 32632016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of TGF-beta signaling by IL-15: a new role for IL-15 in the loss of immune homeostasis in celiac disease.
    Benahmed M; Meresse B; Arnulf B; Barbe U; Mention JJ; Verkarre V; Allez M; Cellier C; Hermine O; Cerf-Bensussan N
    Gastroenterology; 2007 Mar; 132(3):994-1008. PubMed ID: 17324400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TGF-beta-induced SMAD signaling and gene regulation: consequences for extracellular matrix remodeling and wound healing.
    Schiller M; Javelaud D; Mauviel A
    J Dermatol Sci; 2004 Aug; 35(2):83-92. PubMed ID: 15265520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smad2 and Smad3 are redundantly essential for the TGF-beta-mediated regulation of regulatory T plasticity and Th1 development.
    Takimoto T; Wakabayashi Y; Sekiya T; Inoue N; Morita R; Ichiyama K; Takahashi R; Asakawa M; Muto G; Mori T; Hasegawa E; Saika S; Hara T; Nomura M; Yoshimura A
    J Immunol; 2010 Jul; 185(2):842-55. PubMed ID: 20548029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blocking Smad7 restores TGF-beta1 signaling in chronic inflammatory bowel disease.
    Monteleone G; Kumberova A; Croft NM; McKenzie C; Steer HW; MacDonald TT
    J Clin Invest; 2001 Aug; 108(4):601-9. PubMed ID: 11518734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin induces the tolerogenic dendritic cell that promotes differentiation of intestine-protective regulatory T cells.
    Cong Y; Wang L; Konrad A; Schoeb T; Elson CO
    Eur J Immunol; 2009 Nov; 39(11):3134-46. PubMed ID: 19839007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting Smads to restore transforming growth factor-beta signaling and regulatory T-cell function in inflammatory bowel disease.
    Nguyen DD; Snapper SB
    Gastroenterology; 2009 Apr; 136(4):1161-4. PubMed ID: 19236965
    [No Abstract]   [Full Text] [Related]  

  • 19. TGF-beta signaling pathway: its role in gastrointestinal pathophysiology and modulation of ulcer healing.
    Tanigawa T; Pai R; Arakawa T; Higuchi K; Tarnawski AS
    J Physiol Pharmacol; 2005 Mar; 56(1):3-13. PubMed ID: 15795471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The inhibitory effects of transforming growth factor-beta-1 (TGF-beta1) in autoimmune diseases.
    Prud'homme GJ; Piccirillo CA
    J Autoimmun; 2000 Feb; 14(1):23-42. PubMed ID: 10648114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.